Shedding and transmission of novel influenza virus A/H1N1 infection in households--Germany, 2009.
暂无分享,去创建一个
Roland Grunow | Walter Haas | Barbara Biere | Brunhilde Schweiger | Udo Buchholz | Gérard Krause | U. Buchholz | W. Haas | R. Grunow | G. Krause | B. Biere | M. an der Heiden | B. Schweiger | Matthias an der Heiden | Susann Dupke | Thorsten Suess | Alla Heider | A. Heider | S. Dupke | T. Suess | Susann Dupke
[1] L. Finelli,et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. , 2009, The New England journal of medicine.
[2] L. Huson,et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. , 1999, The New England journal of medicine.
[3] A. Monto,et al. Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households. , 2002, The Journal of infectious diseases.
[4] J. Oxford,et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. , 2001, JAMA.
[5] D M Fleming,et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. , 1997, The New England journal of medicine.
[6] H. Goldstein. Multilevel Statistical Models , 2006 .
[7] B. Cowling,et al. Estimation of the Serial Interval of Influenza , 2009, Epidemiology.
[8] Fabrice Carrat,et al. INFLUENZA BURDEN OF ILLNESS: ESTIMATES FROM A NATIONAL PROSPECTIVE SURVEY OF HOUSEHOLD CONTACTS IN FRANCE , 2002, Archives of internal medicine.
[9] Pan Xin,et al. Novel Swine-Origin Influenza A(H1N1) Virus , 2009 .
[10] H. Jackson,et al. Oral Oseltamivir in Human Experimental Influenza B Infection , 1999, Antiviral therapy.
[11] K. Taniguchi,et al. Assessment of secondary attack rate and effectiveness of antiviral prophylaxis among household contacts in an influenza A(H1N1)v outbreak in Kobe, Japan, May-June 2009. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[12] Cécile Viboud,et al. Risk factors of influenza transmission in households. , 2004, The British journal of general practice : the journal of the Royal College of General Practitioners.
[13] C. Carlson,et al. Comparison of Four Clinical Specimen Types for Detection of Influenza A and B Viruses by Optical Immunoassay (FLU OIA Test) and Cell Culture Methods , 1999, Journal of Clinical Microbiology.
[14] William Morris. The American Heritage dictionary of the English language , 1969 .
[15] Mark R. Duffy,et al. Novel Influenza A (H1N1) outbreak at the U.S. Air Force Academy: epidemiology and viral shedding duration. , 2010, American journal of preventive medicine.
[16] P. Ward,et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. , 1999, JAMA.
[17] B. Cowling,et al. Preliminary Findings of a Randomized Trial of Non-Pharmaceutical Interventions to Prevent Influenza Transmission in Households , 2008, PloS one.
[18] H. Klenk,et al. New low-viscosity overlay medium for viral plaque assays , 2006, Virology Journal.
[19] N. Ferguson,et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. , 2008, American journal of epidemiology.
[20] Rosalia M. Kalani,et al. Introduction and transmission of 2009 pandemic influenza A (H1N1) Virus--Kenya, June-July 2009. , 2009, MMWR. Morbidity and mortality weekly report.
[21] David Buckeridge,et al. Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza , 2010, Canadian Medical Association Journal.
[22] K. Carlsen,et al. Comparison of four nasal sampling methods for the detection of viral pathogens by RT-PCR—A GA2LEN project☆ , 2008, Journal of Virological Methods.
[23] J. Peiris,et al. Viral load in patients infected with pandemic H1N1 2009 influenza A virus , 2009, Journal of medical virology.
[24] Leming,et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections , 1997 .
[25] Bin Cao,et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. , 2009, The New England journal of medicine.
[26] C. Fraser,et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. , 2009, The New England journal of medicine.
[27] C. Viboud,et al. A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data , 2004, Statistics in medicine.
[28] Simon Cauchemez,et al. The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom , 2010, PLoS currents.
[29] 林明輝,et al. World Health Organization 2009精蟲分析新標準 , 2012 .
[30] H. Klenk,et al. Overexpression of the α-2,6-Sialyltransferase in MDCK Cells Increases Influenza Virus Sensitivity to Neuraminidase Inhibitors , 2003, Journal of Virology.
[31] E. Lyons,et al. Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings , 2009, Science.
[32] D. Cummings,et al. Strategies for containing an emerging influenza pandemic in Southeast Asia , 2005, Nature.